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Introduction: Extended opioid use prior to surgery has been implicated in poorer 
postoperative outcomes. However, it remains unclear if there is a significant difference 
in postoperative outcomes among preoperative opioid-naïve and opioid-tolerant patients 
who undergo lumbar spinal fusion. The purpose of this study was to determine the 
effect of preoperative opioid use on patient-reported outcome measures in patients 
undergoing lumbar spinal fusion. 
Methods: This retrospective cohort analysis identified 260 patients who underwent 
lumbar spinal fusion at a high-volume, single institution. There were two cohorts: 
patients who were opioid-naïve (defined as total opioid consumption of ≤ 7 days in the 
two months prior to surgery) and opioid-tolerant users (> 7 days). Outcome measures 
were analyzed via the number of and duration of opioid tablets consumed, and patient-
reported outcome measures (ODI, SF-12 PCS and MCS, and VAS Back and Leg pain 
scores). 
Results: Overall, opioid-naïve patients were prescribed significantly fewer tablets on 
average compared to opioid-tolerant users. The number of tablets prescribed prior to 
surgery was a predictor for prolonged opioid use—defined as greater than one script 
after surgery. Opioid-tolerant users had decreased improvement in outcomes 
postoperatively compared to opioid-naïve users. 
Discussion: This study suggests that preoperative opioid-tolerant usage was 
associated with worse outcome scores postoperatively. Opioid-tolerant users were 
found to have significantly more pain medication tablets preoperatively and for a longer 
duration postoperatively. Therefore, opioid-tolerant usage can adversely affect patient 
outcomes and is a modifiable risk factor prior to undergoing lumbar spinal fusion.  
 
